Dutch insect producer Protix attracts further investment

By Jane Byrne contact

- Last updated on GMT

Dutch insect producer Protix attracts further investment

Related tags: Insect, Rabobank

Rabo Corporate Investments (RCI), Rabobank's investment franchise, has invested in Protix, a company that breeds larvae from the Black Soldier Fly (BSF) and processes them into ingredients like proteins and lipids for use in feed.

Rabobank Group has been involved with Protix since its founding more than ten years ago. 


“The undisclosed deal parameters reflect RCI’s belief in the vast potential and importance of insect ingredients and Protix global frontrunner position within this industry.

"Rabobank was an early stage impact investor through Shift/Dutch Greentech Fund. This venture capital focused fund made a successful exit with the successful €45m capital raised in 2017. RCI is the private equity arm of the Rabobank and evaluates deals independently based on the business merits and progress of the company. The early stage arm (Shift/DGF) was through a separate fund backed by Rabobank.

“Now that Protix has met many important new milestones, RCI deems this the time right to once again invest as shareholder. RCI can support Protix with its international expansion and capital raising plans,” ​said Kees Aarts, founder and CEO of Protix.

Last year, Protix opened its insect factory​ in Bergen op Zoom in the Netherlands, the world’s largest, industrial-scale and automated production facility for insect farming. Some €40m was invested in that plant.

Production capacity, international expansion

The insect producer said it intends to use this fresh capital injection from RCI to scale up the production of insect protein and oils in the Netherlands and also to accelerate the roll-out of its international business. 


The proceeds will be applied for further strengthening the growth functions in our organization like business development, engineering and R&D. We will also further expand our ingredient portfolio and it gives Protix room to further [increase] production capacity. Expanding capacity in the Netherlands is definitely also on the list of projects,”​ Aarts told us. 

In terms of when and where international expansion would take place, the CEO said: “We want to expand outside of the Netherlands - in Europe, and in North America – and we are also considering franchising our technology to investors in Asia and South America. The latter is in development and we will communicate more about it at the end of the year or early 2021.”​ 

Related news

Show more

Related products

show more

The future of animal nutrition includes clean feed

The future of animal nutrition includes clean feed

Hamlet Protein | 04-May-2021 | Technical / White Paper

Clean feed is defined by high-quality ingredients that enhance not only nutrient composition and digestibility, but also long-term health and performance....

An expertise worth sharing...

An expertise worth sharing...

Hamlet Protein | 23-Mar-2021 | Technical / White Paper

Scientific research, performance trials and a patented process - we've dedicated it all to creating the most outstanding vegetable proteins for young...

Can soy be the sustainable protein of choice?

Can soy be the sustainable protein of choice?

Hamlet Protein | 02-Mar-2021 | Technical / White Paper

When cultivated and processed in a responsible manner, soy can be the sustainable protein source of choice for animals, consumers and our planet. All our...

Effect of yeast nutritional factors on immune health

Effect of yeast nutritional factors on immune health

Angel Yeast Co., Ltd. | 07-Dec-2020 | Technical / White Paper

The nutritional status of animals affects their immune functions and resistance to diseases. Hence, nutrition deficiency can cause damage to the animal’s...

Related suppliers

Follow us


View more